| Mathematics and Statistics | Lifetime | 514 | CN 34 | 99.17 |
| Medical and Health Sciences | 2021-2025 | 182 | CN 19 | 99.97 |
| Mathematics and Statistics | 2021-2025 | 148 | CN 32 | 98.89 |
| Economics and Finance | 2021-2025 | 645 | CN 139 | 97.51 |
| Epidemiology | Lifetime | 64 | CN 5 | 99.89 |
| Modeling and Simulation | Lifetime | 18 | CN 2 | 99.61 |
| Infectious Diseases | Lifetime | 123 | CN 6 | 99.61 |
| Health | Lifetime | 565 | CN 10 | 96.07 |
| Agronomy and Crop Science | Lifetime | 591 | CN 24 | 95.38 |
| Infectious Diseases | 2021-2025 | 5 | CN 2 | 99.87 |
| Epidemiology | 2021-2025 | 50 | CN 4 | 99.71 |
| Modeling and Simulation | 2021-2025 | 31 | CN 4 | 99.21 |
| Health | 2021-2025 | 92 | CN 4 | 97.73 |
| Econometrics and Quantitative Economics | 2021-2025 | 403 | CN 102 | 97.92 |
| Pulmonary and Respiratory Medicine | 2021-2025 | 636 | CN 77 | 92.41 |
| Clinical Neurology | 2021-2025 | 444 | CN 20 | 84.28 |
| COVID-19 Pandemic Impacts | Lifetime | 2 | CN 1 | 99.82 |
| COVID-19 epidemiological studies | Lifetime | 6 | CN 1 | 99.91 |
| SARS-CoV-2 and COVID-19 Research | Lifetime | 22 | CN 7 | 99.86 |
| Influenza Virus Research Studies | Lifetime | 11 | CN 3 | 99.88 |
| Respiratory viral infections research | Lifetime | 15 | CN 2 | 99.87 |
| COVID-19 Clinical Research Studies | Lifetime | 61 | CN 13 | 99.60 |
| Animal Disease Management and Epidemiology | Lifetime | 27 | CN 3 | 99.69 |
| Data-Driven Disease Surveillance | Lifetime | 9 | CN 2 | 99.21 |
| SARS-CoV-2 detection and testing | Lifetime | 19 | CN 7 | 99.36 |
| Vaccine Coverage and Hesitancy | Lifetime | 33 | CN 1 | 99.51 |
| COVID-19 and Mental Health | Lifetime | 51 | CN 6 | 99.27 |
| Infection Control and Ventilation | Lifetime | 12 | CN 3 | 99.45 |
| Viral Infections and Outbreaks Research | Lifetime | 42 | CN 2 | 99.41 |
| Viral gastroenteritis research and epidemiology | Lifetime | 688 | CN 30 | 98.14 |
| Long-Term Effects of COVID-19 | Lifetime | 499 | CN 39 | 96.34 |
| COVID-19 and healthcare impacts | Lifetime | 422 | CN 14 | 95.07 |
| Viral Infections and Vectors | Lifetime | 666 | CN 21 | 98.07 |
| Viral Infections and Immunology Research | Lifetime | 678 | CN 30 | 96.83 |
| Infection Control in Healthcare | Lifetime | 440 | CN 14 | 89.91 |
| COVID-19 Digital Contact Tracing | Lifetime | 322 | CN 11 | 62.86 |
| COVID-19 epidemiological studies | 2021-2025 | 2 | CN 1 | 99.84 |
| SARS-CoV-2 and COVID-19 Research | 2021-2025 | 8 | CN 1 | 99.89 |
| COVID-19 Clinical Research Studies | 2021-2025 | 15 | CN 2 | 99.84 |
| Influenza Virus Research Studies | 2021-2025 | 2 | CN 1 | 99.83 |
| SARS-CoV-2 detection and testing | 2021-2025 | 3 | CN 1 | 99.57 |
| Respiratory viral infections research | 2021-2025 | 5 | CN 1 | 99.74 |
| Vaccine Coverage and Hesitancy | 2021-2025 | 24 | CN 2 | 99.20 |
| COVID-19 Pandemic Impacts | 2021-2025 | 41 | CN 7 | 98.52 |
| Viral Infections and Outbreaks Research | 2021-2025 | 47 | CN 6 | 96.83 |
| Data-Driven Disease Surveillance | 2021-2025 | 21 | CN 3 | 95.37 |
| Long-Term Effects of COVID-19 | 2021-2025 | 499 | CN 13 | 95.56 |
| COVID-19 and Mental Health | 2021-2025 | 541 | CN 60 | 95.46 |
| COVID-19 and healthcare impacts | 2021-2025 | 594 | CN 15 | 92.10 |
| Infection Control and Ventilation | 2021-2025 | 118 | CN 51 | 94.13 |
| Viral Infections and Immunology Research | 2021-2025 | 408 | CN 106 | 88.97 |
| Animal Disease Management and Epidemiology | 2021-2025 | 942 | CN 193 | 83.17 |
| Heparin-Induced Thrombocytopenia and Thrombosis | 2021-2025 | 815 | CN 35 | 57.77 |
| COVID-19 Digital Contact Tracing | 2021-2025 | 433 | CN 25 | 41.86 |